GLO:PSEGlobe Telecom Inc. Analysis
Data as of 2026-06-09 - not real-time
$5.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
GLO is trading at $5.90, just below its 20‑day SMA of $5.96 but above the 50‑day and 200‑day averages, indicating a modest bullish bias. The 30‑day volatility of roughly 16% and a beta of 0.93 suggest market‑line risk with moderate price swings. RSI sits at 47, implying the stock is neither overbought nor oversold, while the MACD histogram is negative, signaling short‑term bearish momentum. Technical support lies near $5.77 and resistance near $6.10, framing a tight trading range. On the valuation side, the trailing P/E of 5.27 is dramatically below the asset‑management industry average of 16.9, pointing to a potential value discount. The price‑to‑book of 0.90 and dividend yield of 10.9% further underscore the cheapness relative to peers. However, the fund carries a high debt‑to‑equity ratio of 24.7 and total debt of $69.5 million against cash of only $0.04 million, raising leverage concerns. Operating cash flow remains robust at $27.6 million, and free cash flow of $2.38 million supports the generous payout.
The fund announced a monthly distribution on March 31 2026 and an upcoming ex‑dividend date of June 17 2026, reflecting its commitment to income. With a payout ratio of roughly 53%, the dividend appears sustainable given the positive cash‑flow profile. The overall market sentiment is “Extreme Greed” (Fear‑Greed Index 88.98), which may further buoy demand for high‑yield assets. Taken together, the blend of undervalued pricing, strong yield, and manageable risk suggests a cautiously optimistic outlook.
The fund announced a monthly distribution on March 31 2026 and an upcoming ex‑dividend date of June 17 2026, reflecting its commitment to income. With a payout ratio of roughly 53%, the dividend appears sustainable given the positive cash‑flow profile. The overall market sentiment is “Extreme Greed” (Fear‑Greed Index 88.98), which may further buoy demand for high‑yield assets. Taken together, the blend of undervalued pricing, strong yield, and manageable risk suggests a cautiously optimistic outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating short‑term downside pressure
- High dividend yield providing income cushion
- Price near technical support limiting downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E far below industry average suggesting valuation upside
- Sustainable dividend payout supported by strong cash flow
- Potential upside to resistance level around $6.10
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Value‑oriented fundamentals with low price‑to‑book
- Consistent income distribution reinforcing investor demand
- Moderate beta and volatility indicating manageable market risk
Key Metrics & Analysis
Financial Health
Revenue Growth-18.60%
Profit Margin614.60%
P/E Ratio5.3
ROE17.68%
ROA0.43%
Debt/Equity24.66
P/B Ratio0.9
Op. Cash Flow$27.6M
Free Cash Flow$2.4M
Industry P/E16.9
Technical Analysis
TrendBullish
RSI47.1
Support$5.77
Resistance$6.10
MA 20$5.96
MA 50$5.85
MA 200$5.78
MACDBearish
VolumeStable
Fear & Greed Index88.98
Valuation
GradeUndervalued
TypeValue
Dividend Yield10.92%
Risk Assessment
Beta0.93
Volatility16.10%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.